Immunopathology of Autoimmune Myasthenia Gravis: Implications for Improved Testing Algorithms and Treatment Strategies

Rituximab in AChR subtype of myasthenia gravis: systematic review

(2020) Vincenzo Di Stefano et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics

(2020) Konstantinos Lazaridis et al.   Frontiers in Immunology

Anti-LRP4 Antibody-associated Myasthenia Gravis with a Rare Complication of Thymoma Successfully Treated by Thymectomy

(2020) Sho Aoki et al.   INTERNAL MEDICINE

Differential response to rituximab in anti-AChR and anti-MuSK positive myasthenia gravis patients: a single-center retrospective study

(2020) Tess Litchman et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Prognostic predictors of remission in ocular myasthenia after thymectomy

(2020) Xiang Liu et al.   Journal of Thoracic Disease

Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis

(2020) Mariapaola Marino et al.   Frontiers in Immunology

Muscle-Specific Kinase Myasthenia Gravis

(2020) Lucia S. Borges et al.   Frontiers in Immunology

Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology

(2020) Miriam L. Fichtner et al.   Frontiers in Immunology

Efficacy and safety of rituximab in myasthenia gravis: a French multicentre real‐life study

(2020) A. Dos Santos et al.   EUROPEAN JOURNAL OF NEUROLOGY

Eculizumab for the treatment of myasthenia gravis

(2020) Renato Mantegazza et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Effectiveness and safety of thymectomy plus prednisone compares with prednisone monotherapy for the treatment of non-thymomatous Myasthenia Gravis

(2020) Huili Yang et al.   MEDICINE

Clinical features of LRP4 /agrin‐antibody–positive myasthenia gravis: A multicenter study

(2020) Michael H. Rivner et al.   MUSCLE & NERVE

Therapeutic and Diagnostic Challenges in Myasthenia Gravis

(2020) Thy Nguyen et al.   NEUROLOGIC CLINICS

Subgroup Stratification and Outcome in Recently Diagnosed Generalized Myasthenia Gravis

(2020) Matthias Tomschik et al.   NEUROLOGY

A Practical Approach to Managing Patients With Myasthenia Gravis—Opinions and a Review of the Literature

(2020) Maria Elena Farrugia et al.   Frontiers in Neurology

Novel Treatments in Myasthenia Gravis

(2020) Deepak Menon et al.   Frontiers in Neurology

MuSK-Associated Myasthenia Gravis: Clinical Features and Management

(2020) Carmelo Rodolico et al.   Frontiers in Neurology

Management of Juvenile Myasthenia Gravis

(2020) Karen O'Connell et al.   Frontiers in Neurology

Consistent improvement with eculizumab across muscle groups in myasthenia gravis

(2020) Renato Mantegazza et al.   Annals of Clinical and Translational Neurology

Myasthenia gravis

(2019) Nils Erik Gilhus et al.   Nature Reviews Disease Primers

Presence of Multiple Autoimmune Antibodies Involved in Concurrent Myositis and Myocarditis and Myasthenia Gravis Without Thymoma: A Case Report

(2019) Zhijian Zhou et al.   Frontiers in Neurology

Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture

(2019) Koneczny et al.   Cells

Ocular myasthenia gravis

(2019) Andrew T. Melson et al.   CURRENT OPINION IN NEUROLOGY

Serological and experimental studies in different forms of myasthenia gravis

(2018) Angela Vincent et al.   Annals of the New York Academy of Sciences

Multiple antibody detection in ‘seronegative’ myasthenia gravis patients

(2017) Y. Hong et al.   EUROPEAN JOURNAL OF NEUROLOGY

IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients

(2017) Inga Koneczny et al.   JOURNAL OF AUTOIMMUNITY

Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis

(2017) Isabell Cordts et al.   JOURNAL OF NEUROLOGY

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

(2017) James F Howard et al.   LANCET NEUROLOGY

Rituximab treatment of myasthenia gravis: A systematic review

(2017) Rup Tandan et al.   MUSCLE & NERVE

Analysis of peripheral B cells and autoantibodies against the anti-nicotinic acetylcholine receptor derived from patients with myasthenia gravis using single-cell manipulation tools

(2017) Tomohiro Makino et al.   PLoS One

Titin antibodies in “seronegative” myasthenia gravis — A new role for an old antigen

(2016) C. Stergiou et al.   JOURNAL OF NEUROIMMUNOLOGY

Agrin and low-density lipoprotein-related receptor protein 4 antibodies in amyotrophic lateral sclerosis patients

(2016) Michael H. Rivner et al.   MUSCLE & NERVE

Myasthenia gravis — autoantibody characteristics and their implications for therapy

(2016) Nils Erik Gilhus et al.   Nature Reviews Neurology

International consensus guidance for management of myasthenia gravis

(2016) Donald B. Sanders et al.   NEUROLOGY

Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin

(2016) Elena Cortés-Vicente et al.   JAMA Neurology

Detection of Acetylcholine Receptor Modulating Antibodies by Flow Cytometry

(2015) Bucky K. Lozier et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

An update on laboratory diagnosis in myasthenia gravis

(2015) Joel Oger et al.   CLINICA CHIMICA ACTA

MuSK autoantibodies in myasthenia gravis detected by cell based assay — A multinational study

(2015) A.I. Tsonis et al.   JOURNAL OF NEUROIMMUNOLOGY

Collagen Q – A potential target for autoantibodies in myasthenia gravis

(2015) Marta Zoltowska Katarzyna et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Myasthenia gravis: subgroup classification and therapeutic strategies

(2015) Nils Erik Gilhus et al.   LANCET NEUROLOGY

Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis

(2015) Pedro M. Rodríguez Cruz et al.   JAMA Neurology

Collagen Q and anti-MuSK autoantibody competitively suppress agrin/LRP4/MuSK signaling

(2015) Kenji Otsuka et al.   Scientific Reports

Antititin antibody in early- and late-onset myasthenia gravis

(2014) P. Szczudlik et al.   ACTA NEUROLOGICA SCANDINAVICA

Cortactin autoantibodies in myasthenia gravis

(2014) Eduard Gallardo et al.   AUTOIMMUNITY REVIEWS

Myasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanisms

(2014) Sonia Berrih-Aknin et al.   JOURNAL OF AUTOIMMUNITY

Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis

(2014) Raffaele Iorio et al.   JOURNAL OF NEUROLOGY

Cardiac involvements in myasthenia gravis associated with anti-Kv1.4 antibodies

(2013) S. Suzuki et al.   EUROPEAN JOURNAL OF NEUROLOGY

Mesdc2 plays a key role in cell-surface expression of Lrp4 and postsynaptic specialization in myotubes

(2013) Taisuke Hoshi et al.   FEBS LETTERS

A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis

(2013) P. Zisimopoulou et al.   JOURNAL OF AUTOIMMUNITY

Clinical and immunological predictors of prognosis for Japanese patients with thymoma-associated myasthenia gravis

(2013) Shigeaki Suzuki et al.   JOURNAL OF NEUROIMMUNOLOGY

Management of Juvenile Myasthenia Gravis

(2013) Cristian M. Ionita et al.   PEDIATRIC NEUROLOGY

MuSK Myasthenia Gravis IgG4 Disrupts the Interaction of LRP4 with MuSK but Both IgG4 and IgG1-3 Can Disperse Preformed Agrin-Independent AChR Clusters

(2013) Inga Koneczny et al.   PLoS One

MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4

(2013) M. G. Huijbers et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients

(2013) John S. Tzartos et al.   Annals of Clinical and Translational Neurology

The search for new antigenic targets in myasthenia gravis

(2012) Judith Cossins et al.   Annals of the New York Academy of Sciences

Muscle autoantibodies in myasthenia gravis: beyond diagnosis?

(2012) Matthew N Meriggioli et al.   Expert Review of Clinical Immunology

Long-lasting treatment effect of rituximab in MuSK myasthenia

(2012) J. Diaz-Manera et al.   NEUROLOGY

Late Onset Myasthenia Gravis Is Associated with HLA DRB1*15:01 in the Norwegian Population

(2012) Angelina H. Maniaol et al.   PLoS One

Autoantibodies to Lipoprotein-Related Protein 4 in Patients With Double-Seronegative Myasthenia Gravis

(2011) John S. Tzartos   ARCHIVES OF NEUROLOGY

Increasing incidence of myasthenia gravis among elderly in British Columbia, Canada

(2011) Z. Pakzad et al.   NEUROLOGY

Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis

(2010) Osamu Higuchi et al.   ANNALS OF NEUROLOGY

A systematic review of population based epidemiological studies in Myasthenia Gravis

(2010) Aisling S Carr et al.   BMC Neurology

Non-radioactive serological diagnosis of myasthenia gravis and clinical features of patients from Tianjin, China

(2010) Li Yang et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Antigenic Structure of the Human Muscle Nicotinic Acetylcholine Receptor Main Immunogenic Region

(2009) Jie Luo et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Autoimmunizing Mechanisms in Thymoma and Thymus

(2008) Nick Willcox et al.   Annals of the New York Academy of Sciences

Response to Therapy in Myasthenia Gravis with Anti-MuSK Antibodies

(2008) Amelia Evoli et al.   Annals of the New York Academy of Sciences

IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis†

(2008) Maria Isabel Leite et al.   BRAIN

Lrp4 Is a Receptor for Agrin and Forms a Complex with MuSK

(2008) Natalie Kim et al.   CELL

A rapid, fluorescence-based assay for detecting antigenic modulation of the acetylcholine receptor on human cell lines

(2008) Dennis Keefe et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Clinical fluctuations in MuSK myasthenia gravis are related to antigen-specific IgG4 instead of IgG1

(2008) E.H. Niks et al.   JOURNAL OF NEUROIMMUNOLOGY